Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
My blogging and my research rely on rapid, electronic access to the latest publications in all the leading medical, health services research, and health economics
I had the privilege this past Tuesday of debating the merits of Halbig and King with Jonathan Adler, a law professor at Case Western and
I know I’m a little late to this party, but I have an ongoing interest in infant mortality, so I’m going to cover it. Everyone
Last month, Anthem Blue Cross in California (a division WellPoint) announced it is entering a nonexclusive partnership with seven competitive hospital systems in the Los Angeles
I am a frequent guest on Stand Up! with Pete Dominick, which airs on Sirius/XM radio, channel 104 from 6-9AM Eastern. It immediately replays on the channel, so
The following originally appeared on The Upshot (copyright 2014, The New York Times Company). My colleagues Margot Sanger-Katz and Amanda Cox wrote recently that shopping around for
From “Prespecified Falsification End Points: Can They Validate True Observational Associations?” by Vinay Prasad and Anupam Jena: [A]nalyses in large data sets are not necessarily correct simply
A number of people, especially ER docs, have taken exception to this: How common is this, you might ask? When emergency medicine emerged as a
Empirical studies provide facts to help guide policy and clinical medicine, or at least they do when the study is done well. Good studies are reproducible, that is, any competent scientist
What’s the “right” way to decompose health spending growth? That’s a trick question. To find out why, read my new post on the AcademyHealth blog.
For many years, researchers and industry observers have conjectured that rising generic penetration might have an impact on the rate and direction of pharmaceutical innovation.
In JAMA Pediatrics: Pharyngitis is a common reason for pediatric health care visits. While viral infections account for the majority of pharyngitis episodes, group A Streptococcus